Biggest News Aggregation in the World
๐Ÿ“ฐ D News

Page 1023 - D News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from D. Real-time updates on events, politics, business and more.

High Country News | Classifieds | Employment & Education

Compensation: $22,880 - $24,960 (20 hours per.... Communications Manager Employment & Education classified ad of the High Country News Classified Marketplace, Paonia, CO. Browse Employment & Education classified ads and free ads. Post free Employment & Education classified ads.
United States Colorado Plateau Bears Ears Corners Region Bears Ears Partnership Bears Ears Education Center
Source: hcn.org

Combination Regimens Stir Excitement in Advanced RCC

Expert oncologists who treat patients with advanced RCC discuss updates from clinical trials presented during the 2023 European Society for Medical Oncology Congress that further defined the treatment paradigm in advanced RCC and gave a peek into the potential future of the disease management.
United States Neeraj Agarwal Benjaminl Maughan Laurence Albiges American Society Of Clinical Oncology International Metastatic

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Former Maryland social media influencer sentenced for obtaining $1.2M in CARES Act loans

GREENBELT, Md. (DC News Now) — A social media influencer from Maryland was sentenced on Tuesday to three years in federal prison for wire fraud, identity theft and money laundering. He pled guilty to the charges on May 31, 2023. The U.S. Attorney’s Office said that 32-year-old Denish Sahadevan, also known as “Danny Devan,” of […]
United States Denish Sahadevan Danny Devan Us Attorney Office Paycheck Protection Program Small Business Administration
Source: yahoo.com

Dr Kuykendall on the Efficacy of Pelabresib Plus Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis

Andrew Kuykendall, MD, discusses the efficacy of the combination of pelabresib and ruxolitinib in patients with JAK inhibitorโ€“naive myelofibrosis based on data from the phase 3 MANIFEST-2 trial.
Andrew Kuykendall Moffitt Cancer Center Department Of Malignant Hematology Malignant Hematology Pelabresib Cpi 0610 Hase 3 Manifest 2 Trial Nct04603495

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science